A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians

• Main Authors: Sun Young Choi (Author), Young Gue Koh (Author), Yang Won Lee (Author), Hyung Seok Son (Author), Yi Na Yoon (Author), Gyeonghoon Kim (Author), Chonghyun Won (Author), Hyesoo Cho (Author), Joo-Sun Son (Author), Eun-Kyoung Kim (Author), Beom Joon Kim (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Botulinum toxin type A (BoNT-A) was first isolated in 1946, and since then, several formulations have been developed and widely used to treat wrinkles by inducing muscle paralysis. This multicenter, double-blind, randomized, parallel-group, active-controlled phase 3 clinical trial was designed to ev...